Literature DB >> 4353910

Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man.

J Boberg, L A Carlson, S O Fröberg, L Orö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4353910     DOI: 10.1016/0021-9150(70)90074-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  4 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.

Authors:  P H Lenz; A I Fleischman
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

3.  Effects of Su-13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol.

Authors:  R J Cenedella
Journal:  Lipids       Date:  1971-07       Impact factor: 1.880

4.  Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog.

Authors:  R J Cenedella
Journal:  Lipids       Date:  1972-10       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.